Abbott Laboratories 2012 Annual Report Download - page 17

Download and view the complete annual report

Please find page 17 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

Abbott’s robust new-product pipeline contains dozens of potentially transformational medical
technologies, next-generation systems, new formulations, and packaging and brand enhancements.
>30 medical devices in development >150 product launches, registrations in 2013
FreeStyle InsuLinx — Diabetes Care Ensure Complete — Nutrition
Vision Care
In vision care, we are developing new
diagnostic instruments and treatments
to improve vision outcomes, including
new applications in our market-
leading LASIK platform and continued
expansion of our Tecnis line of
intraocular lens (IOL) products. We
are also developing products
specifically designed to address the
needs of emerging markets such as
India and China.
Diabetes Care
Research in diabetes care is focused
on addressing the unmet needs of
insulin users and providing treatment
insights for healthcare professionals.
Current innovations in our pipeline
include meters that provide tools
for insulin users and state-of-the-
art software to help healthcare
professionals more easily recognize
glucose trends.
Nutrition
We’re focusing research on six
health benefit platforms in which we
believe better nutrition can have a
significant impact on overall health:
immunity, cognition, lean body
mass, inflammation, metabolism and
tolerance. We’re currently conducting
a number of controlled clinical trials to
demonstrate proven outcomes from our
nutrition innovations, and we expect to
launch a number of new products and
formulations in the coming years.
15
Abbott 2012 Annual Report